- News article -

Customer success-story: Optomed secured 1,97 M€ EU funding for Smartscope-X – affordable, accessible and automatic screening for diabetic retinopathy

12 Oct 2017

In May, the Finnish medical technology company Optomed was granted 1,97 M€ from Horizon 2020 SME Phase 2 instrument under the topic Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well. The funding will help Optomed make their product Smartscope-X the leading solution for diabetic retinopathy screening, supporting the company’s vision to provide affordable eye screenings to everyone.

Diabetic retinopathy is the most frequent cause of preventable blindness in working-aged adults, affecting people with all types of diabetes. Visual impairment and blindness caused by diabetic retinopathy can be prevented through early and effective screening. Currently, screening is costly, time-consuming and needs to be done by an ophthalmologist. Optomed’s solution will allow patients to do the screenings automatically and get the diagnosis in real-time.

Optomed’s fully automated diabetic retinopathy screening solution consists of three main components: a low-cost handheld camera, an automated screening algorithm and a cloud service for eyeground images. As a low-cost and portable solution, Smartscope-X can also provide access to screening for example in developing countries.

Spinverse supported Optomed in project preparation, including help in defining the scope, matching the call and assisting in writing the proposal. After a positive decision from the EU Commission in May 2017, Spinverse supported Optomed in the project negotiation phase.

“The cooperation with Spinverse worked well. The applicant always has the main responsibility during the application process, but the support from Spinverse and their expertise on the application process helped us achieve the desired outcome,” says Seppo Kopsala, CEO of Optomed.

The project officially began in August. Currently, Optomed is working on product development related to the integration between the camera and the software as well as choosing subcontractors for the server solution. Next steps towards the commercialization of Smartscope-X include several clinical tests and commercial pilots in target countries during 2018–2019.

What can you achieve with EU funding? See how we have helped companies create success stories and  contact us to discuss your options.

Photo credit: Optomed

- News -

Relevant posts

EU funding Green Deal

Europe invests in green technologies despite the corona crisis

27 Mar 2020

Europe is committed to be the first climate-neutral continent in the world and to reach this goal, the Europ...

Open Innovation edtech

Koulu.me highlights Finnish edtech companies for pedagogical content

27 Mar 2020

To support teachers in their important educational work during the coronavirus pandemic, Spinverse launched ...

startups News

Finnish edtech companies unite to offer free access to distance learning apps for coronavirus-stricken schools

16 Mar 2020

The ongoing coronavirus outbreak is closing schools worldwide and confines teachers and students at their ho...

startups News

Suomalaiset oppimisteknologian pioneerit tarjoavat ratkaisujaan etäopiskeluun ilmaiseksi koronan aikana

16 Mar 2020

Maailmaa ravisteleva koronaviruspandemia sulkee kouluja, jonka seurauksena opettajat ja oppilaat joutuvat j...

university Funding Partners

How Tampere University revolutionized their process of finding the suitable funding opportunities for future projects

12 Mar 2020

Spinbase is a tool developed by Spinverse to ease the complex task of finding the most suitable EU funding i...

Spinverse innovation ecosystem

Leading innovation ecosystems — leading complexity

11 Mar 2020

Solving big and complex global challenges in urbanisation, climate change and healthcare calls for innovativ...